Generic Aloxi launches from Dr. Reddy’s

Press enter to search
Close search
Open Menu

Generic Aloxi launches from Dr. Reddy’s

By David Salazar - 03/27/2018
Dr. Reddy’s Laboratories has introduced its generic Aloxi (palonosetron hydrochloride injection). The drug, which had been previously approved by the Food and Drug Administration, is indicated to treat chemotherapy-induced nausea and vomiting in adults.

Dr. Reddy’s generic Aloxi will be available in 0.25 mg/5 ml dosage strength. It will be packaged in a carton containing one single-dose vial. The drug’s market size is roughly $446 million for the 12 months ended January 2018, according to IQVIA data.

RELATED TOPICS